Integrated Treatment of Aqueous Extract of <i>Solanum nigrum</i>-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells

<div>AE-SN treatment inhibited Hep3B and HepJ5 cell growth. (a) Hep3B and HepJ5 cells were treated with 0.1 to 2 mg/mL of AE-SN for 48 h, and the cell viability was determined using an MTT assay. The data are presented as the mean ± standard deviation. (b) Hep3B and HepJ5 cells were treated with 1.0 mg/mL of AE-SN for 48 h, and the cell size distribution was determined according to the cell diameter by using a Scepter cell counter. Arrows indicate a cell diameter of 12 <i>μ</i>m.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Integrated Treatment of Aqueous Extract of <i>Solanum nigrum</i>-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells 

Figure 2 | Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells 